Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to establish a benchmark for rate of prescription of oral anticoagulants (OA) in patients with non-valvular atrial fibrillation (NVAF) seen in an ambulatory care setting, based on independent medical assessment of clinical data and physician and patient surveys. The study will also assess reasons for not prescribing OA to prevent thromboembolic complications in patients with NVAF seen in ambulatory care, and patients' perspectives of non-use of OA for treatment of NVAF.


Clinical Trial Description

At participating centers within the American College of Cardiology's (ACC) PINNACLE Registry, patients with nonvalvular atrial fibrillation who, according to ACC guidelines, are indicated as having an indication for oral anticoagulants (OA), but who are not receiving them, will be identified. Recruitment of participating physicians will also take place through collaboration with the PINNACLE Registry. Physician and patient participants will be asked to complete clinical surveys characterizing use and perception of OA therapy for each individual patient. The Baim Institute for Clinical Research (Baim Institute) serves as an analytic center for the PINNACLE Registry and will collaboratively lead this project with the ACC. The information collected from the PINNACLE Registry will include patient characteristics, site characteristics (volume, region, etc.) and the treating physician characteristics. Information from the patient and physician surveys will provide the clinical reasons for prior nontreatment as assessed by the treating physicians as well as the patients' perception of OA treatment (overall and according to pre-specified subgroups based on patient and site characteristics). Information will also be gathered from the patients' chart. The above data will be compiled and reviewed by a committee of cardiologists who will assess whether OA treatment would be appropriate based on all the clinical factors assessed. The BOAT-AF data will be linked to data from the PINNACLE Registry for the patients for whom surveys have been collected. Linking the two datasets will allow assessment of whether or not the participating physicians prescribed OA treatment and whether those patients started OA treatment within approximately 12 months after completing the questionnaire. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02919982
Study type Observational [Patient Registry]
Source Baim Institute for Clinical Research
Contact
Status Completed
Phase
Start date January 2017
Completion date September 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04586972 - Safety and Efficacy of Apixaban in Very Old Geriatric Subjects (> 80 Years) With Atrial FIbrillation in a Prospective reAl World Study;
Completed NCT02007655 - Eliquis Safety Surveillance in Japanese Patients With NonValvular Atrial Fibrillation
Completed NCT02674594 - Evaluation of Hospital Readmissions Among Hospitalized Non-valvular Atrial Fibrillation (NVAF) Patients in the US N/A
Recruiting NCT04494347 - Watchman for Patients With Atrial Fibrillation Undergoing Transcatheter Mitral Valve Repair (WATCH-TMVR) N/A
Not yet recruiting NCT04942873 - The Adherence to Oral Anticoagulant in Chinese Patients With NVAF
Recruiting NCT05731882 - First in Man Study of Left Atrial Appendage Pulsed Field Ablation Occluder N/A
Completed NCT01885598 - Eliquis Regulatory Post Marketing Surveillance N/A
Completed NCT00684307 - Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation Phase 2
Recruiting NCT04073316 - AntiCoagulants and COGnition Phase 4
Completed NCT03374540 - Rivaroxaban vs Warfarin for SPAF in Multi-morbid Patients
Recruiting NCT05715658 - Pharmacokinetic Study to Evaluate Dabigatran Etexilate in Elderly Subjects N/A